ANOVA LAML specific result package

Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 12:31:01
iorio@ebi.ac.uk


Drug Domain: GDSC1000_paper_set, Analysis Domain: LAML specific


Individual Feature analysis: NRAS_mut


Feature details and cell panel numbers

Binary feature equal to 1 for samples harboring mutations in NRAS

Number of cell lines positive for this feature: 8


Statistically significant associations identified = 19
association id
FEATURE
Drug id
Propr
Public
Drug Name
Drug Target
N FEATURE pos
N FEATURE neg
log max Conc tested
FEATURE neg logIC50 MEAN
FEATURE pos logIC50 MEAN
FEATURE deltaMEAN IC50
FEATURE IC50 effectSize
FEATURE neg Glass delta
FEATURE pos Glass delta
ANOVA FEATURE pval
Tissue ANOVA pval
MSI ANOVA pval
ANOVA FEATURE FDR %
a2
NRAS_mut
305
1
1
TPCA-1
IKK
7
18
3
-0.0249
2.38
2.41
2.6 **
2.4 **
3 **
6.26e-06
NA
3.58e-03
0.38
a3
NRAS_mut
306
1
1
TG101348
JAK2
7
19
2.33
-0.781
1.4
2.18
2.2 **
2.1 **
2.8 **
5.67e-05
NA
3.68e-02
2.3
a4
NRAS_mut
290
1
1
KIN001-260
IKK
7
18
3
2.33
3.96
1.64
2.1 **
2.3 **
1.8 *
1.37e-04
NA
8.03e-02
2.9
a5
NRAS_mut
190
1
1
Bleomycin
DNA damage
7
18
4.16
0.562
3.89
3.33
2.1 **
1.9 *
4.3 **
1.46e-04
NA
9.13e-02
2.9
a6
NRAS_mut
157
1
1
JNK-9L
JNK
7
19
1.63
-0.955
0.103
1.06
2.1 **
2.2 **
1.8 *
1.47e-04
NA
1.04e-01
2.9
a7
NRAS_mut
178
1
1
BAY 61-3606
SYK
7
18
2.08
0.491
2.86
2.36
2.1 **
2.2 **
1.8 *
1.67e-04
NA
2.85e-01
2.9
a9
NRAS_mut
177
1
1
GSK-650394
SGK3
7
17
2.77
1.52
4.19
2.68
2.1 **
1.9 *
3 **
2.36e-04
NA
2.39e-01
3
a10
NRAS_mut
134
1
1
Etoposide
TOP2
7
19
2.77
0.114
2.92
2.8
2 *
2.1 **
1.7 *
2.47e-04
NA
3.59e-01
3
a12
NRAS_mut
133
1
1
Doxorubicin
DNA intercalating
7
18
0.0237
-2.47
-0.24
2.23
2 *
2.3 **
1.5 *
3.3e-04
NA
5.1e-01
3.2
a14
NRAS_mut
302
1
1
PI-103
PI3Ka, PRKDC (DNAPK)
7
19
2.33
-2.24
0.595
2.84
1.9 *
2.1 **
1.5 *
3.98e-04
NA
1.65e-02
3.3
a15
NRAS_mut
71
1
1
Pyrimethamine
Dihydrofolate reductase (DHFR)
7
19
3
2.78
4.84
2.06
1.7 *
1.5 *
4 **
4.45e-04
NA
5.23e-01
3.3
a16
NRAS_mut
238
1
1
CAL-101
PI3Kdelta
7
19
3.00, 2.33
2.09
3.99
1.9
1.9 *
2 *
1.7 *
4.51e-04
NA
5.21e-02
3.3
a17
NRAS_mut
299
1
1
OSI-027
MTORC1/2
7
19
3
-1.88
0.296
2.17
1.6 *
1.9 *
1.2 *
4.61e-04
NA
1.06e-04
3.3
a18
NRAS_mut
35
1
1
NVP-TAE684
ALK
7
19
0.693
-0.537
1.46
1.99
1.9 *
1.9 *
1.8 *
5.48e-04
NA
2.5e-01
3.3
a19
NRAS_mut
194
1
1
AUY922
HSP90
7
18
-1.36
-4.14
-2.67
1.47
1.9 *
2 **
1.5 *
5.57e-04
NA
4.8e-02
3.3
a21
NRAS_mut
309
1
1
Y-39983
ROCK
7
18
3
2.05
4.12
2.07
1.9 *
1.8 *
2.2 **
5.71e-04
NA
2.15e-01
3.3
a22
NRAS_mut
152
1
1
CP466722
ATM
7
19
2.77
0.62
2
1.38
1.8 *
1.9 *
1.8 *
6.04e-04
NA
3.78e-01
3.4
a23
NRAS_mut
310
1
1
YM201636
FYV1
7
18
1.63
0.701
1.96
1.26
1.9 *
2.4 **
1.3 *
6.41e-04
NA
2.02e-01
3.4
a24
NRAS_mut
253
1
1
XMD14-99
EPHB3, CAMK1
7
19
2.33
2.65
4
1.36
1.8 *
2 *
1.5 *
6.61e-04
NA
4.73e-01
3.4


All-tests volcano plot